These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 27579518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T.
    Reprod Health; 2015 Jan 16; 12():7. PubMed ID: 25595199
    [Abstract] [Full Text] [Related]

  • 4. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study.
    Hosseinpanah F, Barzin M, Tehrani FR, Azizi F.
    Clin Endocrinol (Oxf); 2011 Nov 16; 75(5):692-7. PubMed ID: 21592169
    [Abstract] [Full Text] [Related]

  • 5. Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.
    Goverde AJ, van Koert AJ, Eijkemans MJ, Knauff EA, Westerveld HE, Fauser BC, Broekmans FJ.
    Hum Reprod; 2009 Mar 16; 24(3):710-7. PubMed ID: 19095675
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Significance of measuring anthropometric and atherogenic indices in patients with polycystic ovary syndrome.
    Uysal E, Tammo O, Soylemez E, Incebıyık M, Filiz D, Alci M.
    BMC Endocr Disord; 2024 Aug 28; 24(1):160. PubMed ID: 39198818
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
    Lankarani M, Valizadeh N, Heshmat R, Peimani M, Sohrabvand F.
    Gynecol Endocrinol; 2009 Aug 28; 25(8):504-7. PubMed ID: 19499403
    [Abstract] [Full Text] [Related]

  • 14. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I, Algun E, Incecayir O, Ersoy K.
    Metab Syndr Relat Disord; 2011 Oct 28; 9(5):375-80. PubMed ID: 21657888
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Waist-to-height ratio and BMI as predictive markers for insulin resistance in women with PCOS in Kolkata, India.
    Bhattacharya K, Sengupta P, Dutta S, Chaudhuri P, Das Mukhopadhyay L, Syamal AK.
    Endocrine; 2021 Apr 28; 72(1):86-95. PubMed ID: 33400176
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.